[Anemia in heart failure. Future therapeutic target?].
Grigorian Shamagian
Lilian
L
González-Juanatey
José Ramón
JR
D000740:Anemia / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015331:Cohort Studies; D015897:Comorbidity; D004232:Diuretics / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D005544:Forecasting; D006333:Heart Failure / Q000097:blood* / Q000150:complications; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy; D015995:Prevalence; D011379:Prognosis; D013318:Stroke Volume
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D004921:Erythropoietin; D007501:Iron